...Thank you, Carlo, and welcome, everyone who's joined the call this morning. I'm joined on the call by Dr. Shai Gozani, our President and Chief Executive Officer. NeuroMetrix develops and commercializes neurostimulation-based medical devices for the diagnosis and treatment of chronic health conditions. Our commercial products are DPNCheck, ADVANCE and Quell. DPNCheck is a point-of-care test for the detection of peripheral neuropathies. ADVANCE is a point-of-care device that provides nerve conduction studies as an aid in diagnosing and evaluating patients suspected of having focal or systemic neuropathies. And Quell is a wearable mobile-app-enabled neurostimulation device indicated for symptomatic relief and management of chronic pain. It is available over the counter. The second quarter of 2020 was a continuation of the suppressed business activity evident in late Q1 of this year as a result of the COVID-19 pandemic. Late in the second quarter, during the month of June, we saw a modest increase...
